No association of SLC6A3 and SLC6A4 gene polymorphisms with schizophrenia in the Han Chinese population

Neuroscience Letters

Volumn 579, Issue , 2014, Pages 114-118

  Yang, Beimeng ^a,b   Huang, Xiaoye ^a,c   Ruan, Liemin ^d   Yu, Tao ^a,c   Li, Xin ^a,c   Jesse, Forrest Fabian ^e   Cao, Yanfei ^a,c   Li, Xingwang ^a,c   Liu, Baocheng ^a,c   Yang, Fengping ^a,c   Lee, Yong Seok ^f   He, Lin ^a,b,c   Li, Weidong ^a,b   He, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANDONG MENTAL HEALTH CENTER   (China)

^c Chinese Academy of Sciences   (China)

^d NINGBO FIRST HOSPITAL   (China)

^e BEIJING JIAOTONG UNIVERSITY   (China)

^f Chung Ang University   (South Korea)

Author keywords

Case control study; Schizophrenia; SLC6A; SLC6A3; SLC6A4

Indexed keywords

DOPAMINE TRANSPORTER; GENOMIC DNA; SEROTONIN TRANSPORTER; SLC6A3 PROTEIN, HUMAN; SLC6A4 PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ADULT; ARTICLE; AUTOSOME; CASE CONTROL STUDY; CONTROLLED STUDY; DSM-IV; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A3 GENE; SLC6A4 GENE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETICS; MIDDLE AGED;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84905221050     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.07.004     Document Type: Article

References (43)

1. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull. World Health Organ. 2000, 78:413-426.
2. Barrett J.C., Fry B., Maller J., Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Bloch B., Reshef A., Cohen T., Tafla A., Gathas S., Israel S., Gritsenko I., Kremer I., Ebstein R.P. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. Psychiatry Res. 2010, 175:38-42.
4. Broer S. The SLC6 orphans are forming a family of amino acid transporters. Neurochem. Int. 2006, 48:559-567.
5. Broer S., Gether U. The solute carrier 6 family of transporters. Brit. J. Pharmacol. 2012, 167:256-278.
6. Carboni E., Tanda G., Frau R., Chiara G.D. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 1990, 55:1067-1070.
7. Cardno A.G., Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 2000, 97:12-17.
8. Carlström E.L., Saetre P., Rosengren A., Thygesen J.H., Djurovic S., Melle I., Andreassen O.A., Werge T., Agartz I., Hall H. Association between a genetic variant in the serotonin transporter gene (SLC6A4) and suicidal behavior in patients with schizophrenia. Behav. Brain Funct. 2012, 8:24.
9. Chen N.-H., Reith M.E., Quick M.W. Synaptic uptake and beyond: the sodium-and chloride-dependent neurotransmitter transporter family SLC6. Pflügers Arch. 2004, 447:519-531.
10. Cordeiro Q., Siqueira-Roberto J., Vallada H. Association between the SLC6A3 A1343G polymorphism and schizophrenia. Arquivos de neuro-psiquiatria 2010, 68:716-719.
11. Cordeiro Q., Talkowski M., Wood J., Ikenaga E., Vallada H. Lack of association between VNTR polymorphism of dopamine transporter gene (SLC6A3) and schizophrenia in a Brazilian sample. Arquivos de neuro-psiquiatria 2004, 62:973-976.
12. Pal P., Mihanović M., Molnar S., Xi H., Sun G., Guha S., Jeran N., Tomljenović A., Malnar A., Missoni S. Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population. Croat. Med. J. 2009, 50:361-369.
13. Shi J., Gershon E.S., Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr. Res. 2008, 104:96-107.
14. Fanous A.H., Neale M., Straub R., Webb B., O'Neill A., Walsh D., Kendler K. Clinical features of psychotic disorders and polymorphisms in HT2A, DRD2, DRD4, SLC6A3 (DAT1), and BDNF: a family based association study. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2004, 125:69-78.
15. Freedman R. Schizophrenia. N. Engl. J. Med. 2003, 349:1738-1749.
16. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science (New York, NY) 1999, 283:397-401.
17. Greenwood T.A., Alexander M., Keck P.E., McElroy S., Sadovnick A.D., Remick R.A., Kelsoe J.R. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am. J. Med. Genet. 2001, 105:145-151.
18. Li W., Yang Y., Lin J., Wang S., Zhao J., Yang G., Wang X., Ding M., Zhang H., Lv L. Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 44:290-295.
19. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Ozaki N. No association of serotonin transporter gene (SLC6A4) with schizophrenia and bipolar disorder in Japanese patients: association analysis based on linkage disequilibrium. J. Neural Transm. 2006, 113:899-905.
20. Kang A.M., Palmatier M.A., Kidd K.K. Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiatry 1999, 46:151-160.
21. Kawarai T., Kawakami H., Yamamura Y., Nakamura S. Structure and organization of the gene encoding human dopamine transporter. Gene 1997, 195:11-18.
22. Laasonen-Balk T., Kuikka J., Viinamaki H., Husso-Saastamoinen M., Lehtonen J., Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology 1999, 144:282-285.
23. 123I] β-CIT. Biol. Psychiatry 2000, 47:371-379.
24. Li X.W., Liu B.C., Wang Y., Zhao Q.Z., Shen Q., Yu T., Chen S.Q., Yang F.P., Li W.D., Gao L.H., Xu Y.F., Feng G.Y., He L., He G. Association study on the DLG4 gene and schizophrenia in the Chinese Han population. Psychiatr. Genet. 2013, 23:247-250.
25. Lin C., Tang W., Hu J., Gao L., Huang K., Xu Y., He G., Liang P., Feng G., He L. Haplotype analysis confirms association of the serotonin transporter (5-HTT) gene with schizophrenia in the Han Chinese population. Neurosci. Lett. 2009, 453:210-213.
26. McDougle C., Epperson C., Price L., Gelernter J. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol. Psychiatry 1998, 3:270-273.
27. McGuffin P., Owen M.J., O'Donovan M.C., Thapar A., Gottesman I. Seminars in psychiatric genetics. BMJ 1994, 309:818.
28. Pezawas L., Meyer-Lindenberg A., Goldman A., Verchinski B., Chen G., Kolachana B., Egan M., Mattay V., Hariri A., Weinberger D. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol. Psychiatry 2008, 13:709-716.
29. Philibert R.A., Sandhu H., Hollenbeck N., Gunter T., Adams W., Madan A. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am. J. Med. Genet. B: Neuropsych. Genet. 2008, 147:543-549.
30. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:2542-2546.
31. Sáiz P.A., García-Portilla M.P., Arango C., Morales B., Arias B., Corcoran P., Fernández J.M., Alvarez V., Coto E., Bascarán M.-T. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: data from an association study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2010, 34:26-31.
32. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2:e141.
33. Sano A., Kondoh K., Kakimoto Y., Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum. Genet. 1993, 91:405-406.
34. Shen Q., Zhang J., Wang Y., Liu B., Li X., Zhao Q., Chen S., Ji J., Yang F., Wan C., Gao L., Xu Y., Feng G., He L., He G. No association between the KCNH1, KCNJ10 and KCNN3 genes and schizophrenia in the Han Chinese population. Neurosci. Lett. 2011, 487:61-65.
35. Squire L.R., Berg D., Bloom F.E., Du Lac S., Ghosh A. Fundamental Neuroscience 2012, 131-204.
36. Sutcliffe J.S., Delahanty R.J., Prasad H.C., McCauley J.L., Han Q., Jiang L., Li C., Folstein S.E., Blakely R.D. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 2005, 77:265-279.
37. van der Wee N.J., van Veen J.F., Stevens H., van Vliet I.M., van Rijk P.P., Westenberg H.G. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J. Nucl. Med. 2008, 49:757-763.
38. van Os J., Kapur S. Schizophrenia. Lancet 2009, 374:635-645.
39. Vijayan N.N., Iwayama Y., Koshy L.V., Natarajan C., Nair C., Allencherry P.M., Yoshikawa T., Banerjee M. Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population. J. Hum. Genet. 2009, 54:538-542.
40. Yang B., Chan R.C., Jing J., Li T., Sham P., Chen R.Y. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2007, 144:541-550.
41. Yong Y., Lin H. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
42. Zhang A., Xing Q., Wang L., Du J., Yu L., Lin Z., Li X., Feng G., He L. Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics 2007, 8:1337-1345.
43. Rousset F. genepop'007: a complete re-implementation of the genepop software for Windows and Linux. Molecular ecology resources 2008, 8:103-106.